The number of publications on deep learning for cancer diagnostics is rapidly increasing, and systems are frequently claimed to perform comparable with or better than clinicians. However, few systems have yet demonstrated real-world medical utility. In this Perspective, we discuss reasons for the moderate progress and describe remedies designed to facilitate transition to the clinic. Recent, presumably influential, deep learning studies in cancer diagnostics, of which the vast majority used images as input to the system, are evaluated to reveal the status of the field. By manipulating real data, we then exemplify that much and varied training data facilitate the generalizability of neural networks and thus the ability to use them clinically. To reduce the risk of biased performance estimation of deep learning systems, we advocate evaluation in external cohorts and strongly advise that the planned analyses, including a predefined primary analysis, are described in a protocol preferentially stored in an online repository. Recommended protocol items should be established for the field, and we present our suggestions.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
npj Digital Medicine Open Access 11 July 2022
Nature Medicine Open Access 25 April 2022
Human-level COVID-19 diagnosis from low-dose CT scans using a two-stage time-distributed capsule network
Scientific Reports Open Access 22 March 2022
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Schmidhuber, J. Deep learning in neural networks: an overview. Neural Netw. 61, 85–117 (2015).
LeCun, Y., Bengio, Y. & Hinton, G. Deep learning. Nature 521, 436–444 (2015).
Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H. & Aerts, H. J. W. L. Artificial intelligence in radiology. Nat. Rev. Cancer 18, 500–510 (2018).
Vamathevan, J. et al. Applications of machine learning in drug discovery and development. Nat. Rev. Drug Discov. 18, 463–477 (2019).
Bera, K., Schalper, K. A., Rimm, D. L., Velcheti, V. & Madabhushi, A. Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology. Nat. Rev. Clin. Oncol. 16, 703–715 (2019).
Nagendran, M. et al. Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies. BMJ 368, m689 (2020).
Kim, D. W., Jang, H. Y., Kim, K. W., Shin, Y. & Park, S. H. Design characteristics of studies reporting the performance of artificial intelligence algorithms for diagnostic analysis of medical images: results from recently published papers. Korean J. Radiol. 20, 405–410 (2019).
Liu, X. et al. A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. Lancet Digit. Health 1, e271–e297 (2019).
Ross, C. & Swetlitz, I. IBM’s Watson supercomputer recommended ‘unsafe and incorrect’ cancer treatments, internal documents show. STAT https://www.statnews.com/2018/07/25/ibm-watson-recommended-unsafe-incorrect-treatments/ (2018).
Narla, A., Kuprel, B., Sarin, K., Novoa, R. & Ko, J. Automated classification of skin lesions: from pixels to practice. J. Invest. Dermatol. 138, 2108–2110 (2018).
Zech, J. R. et al. Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: a cross-sectional study. PLoS Med. 15, e1002683 (2018).
Winkler, J. K. et al. Association between surgical skin markings in dermoscopic images and diagnostic performance of a deep learning convolutional neural network for melanoma recognition. JAMA Dermatol. 155, 1135–1141 (2019).
Rueckert, D. & Schnabel, J. A. Model-based and data-driven strategies in medical image computing. Proc. IEEE 108, 110–124 (2020).
Zhang, C., Bengio, S., Hardt, M., Recht, B. & Vinyals, O. Understanding deep learning requires rethinking generalization. Proc. Int. Conf. Learn. Represent. https://arxiv.org/abs/1611.03530 (2017).
Liu, Y., Chen, P.-H. C., Krause, J. & Peng, L. How to read articles that use machine learning: users’ guides to the medical literature. JAMA 322, 1806–1816 (2019).
Ransohoff, D. F. Bias as a threat to the validity of cancer molecular-marker research. Nat. Rev. Cancer 5, 142–149 (2005).
Moons, K. G. M. et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann. Intern. Med. 170, W1–W33 (2019).
Simard, P., Victorri, B., LeCun, Y. & Denker, J. Tangent Prop — a formalism for specifying selected invariances in an adaptive network. Adv. Neural Inf. Process. Syst. 4, 895–903 (1992).
Shorten, C. & Khoshgoftaar, T. M. A survey on image data augmentation for deep learning. J. Big Data 6, 60 (2019).
Ioannidis, J. P. A. What have we (not) learnt from millions of scientific papers with P values? Am. Stat. 73, 20–25 (2019).
Ioannidis, J. P. A. Why most published research findings are false. PLoS Med. 2, e124 (2005).
Moons, K. G. M. et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): explanation and elaboration. Ann. Intern. Med. 162, W1–W73 (2015).
Heaven, D. Why deep-learning AIs are so easy to fool. Nature 574, 163–166 (2019).
Ioannidis, J. P. A. Evolution and translation of research findings: from bench to where? PLoS Clin. Trials 1, e36 (2006).
Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 25, 44–56 (2019).
Justice, A. C., Covinsky, K. E. & Berlin, J. A. Assessing the generalizability of prognostic information. Ann. Intern. Med. 130, 515–524 (1999).
Subbaswamy, A. & Saria, S. From development to deployment: dataset shift, causality, and shift-stable models in health AI. Biostatistics 21, 345–352 (2020).
Ioannidis, J. P. A. & Khoury, M. J. Improving validation practices in “omics” research. Science 334, 1230–1232 (2011).
Obermeyer, Z. & Emanuel, E. J. Predicting the future — big data, machine learning, and clinical medicine. N. Engl. J. Med. 375, 1216–1219 (2016).
Keane, P. A. & Topol, E. J. With an eye to AI and autonomous diagnosis. NPJ Digit. Med. 1, 40 (2018).
Gianfrancesco, M. A., Tamang, S., Yazdany, J. & Schmajuk, G. Potential biases in machine learning algorithms using electronic health record data. JAMA Intern. Med. 178, 1544–1547 (2018).
Noor, P. Can we trust AI not to further embed racial bias and prejudice? BMJ 368, m363 (2020).
Luo, W. et al. Guidelines for developing and reporting machine learning predictive models in biomedical research: a multidisciplinary view. J. Med. Internet Res. 18, e323 (2016).
Hua, K. L., Hsu, C. H., Hidayati, S. C., Cheng, W. H. & Chen, Y. J. Computer-aided classification of lung nodules on computed tomography images via deep learning technique. Onco Targets Ther. 8, 2015–2022 (2015).
Ciompi, F. et al. Automatic classification of pulmonary peri-fissural nodules in computed tomography using an ensemble of 2D views and a convolutional neural network out-of-the-box. Med. Image Anal. 26, 195–202 (2015).
Arevalo, J., González, F. A., Ramos-Pollán, R., Oliveira, J. L. & Guevara Lopez, M. A. Representation learning for mammography mass lesion classification with convolutional neural networks. Comput. Methods Prog. Biomed. 127, 248–257 (2016).
Setio, A. A. A. et al. Pulmonary nodule detection in CT images: false positive reduction using multi-view convolutional networks. IEEE Trans. Med. Imaging 35, 1160–1169 (2016).
Roth, H. R. et al. Improving computer-aided detection using convolutional neural networks and random view aggregation. IEEE Trans. Med. Imaging 35, 1170–1181 (2016).
Kallenberg, M. et al. Unsupervised deep learning applied to breast density segmentation and mammographic risk scoring. IEEE Trans. Med. Imaging 35, 1322–1331 (2016).
Litjens, G. et al. Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis. Sci. Rep. 6, 26286 (2016).
Huynh, B. Q., Li, H. & Giger, M. L. Digital mammographic tumor classification using transfer learning from deep convolutional neural networks. J. Med. Imaging 3, 034501 (2016).
Nie, K. et al. Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin. Cancer Res. 22, 5256–5264 (2016).
Kooi, T. et al. Large scale deep learning for computer aided detection of mammographic lesions. Med. Image Anal. 35, 303–312 (2017).
Esteva, A. et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 542, 115–118 (2017).
Dhungel, N., Carneiro, G. & Bradley, A. P. A deep learning approach for the analysis of masses in mammograms with minimal user intervention. Med. Image Anal. 37, 114–128 (2017).
Yu, L., Chen, H., Dou, Q., Qin, J. & Heng, P. Automated melanoma recognition in dermoscopy images via very deep residual networks. IEEE Trans. Med. Imaging 36, 994–1004 (2017).
Sun, W., Tseng, T. B., Zhang, J. & Qian, W. Enhancing deep convolutional neural network scheme for breast cancer diagnosis with unlabeled data. Comput. Med. Imaging Graph. 57, 4–9 (2017).
Cruz-Roa, A. et al. Accurate and reproducible invasive breast cancer detection in whole-slide images: a deep learning approach for quantifying tumor extent. Sci. Rep. 7, 46450 (2017).
Ciompi, F. et al. Towards automatic pulmonary nodule management in lung cancer screening with deep learning. Sci. Rep. 7, 46479 (2017).
Araújo, T. et al. Classification of breast cancer histology images using convolutional neural networks. PLoS ONE 12, e0177544 (2017).
Becker, A. S. et al. Deep learning in mammography: diagnostic accuracy of a multipurpose image analysis software in the detection of breast cancer. Invest. Radiol. 52, 434–440 (2017).
Dou, Q., Chen, H., Yu, L., Qin, J. & Heng, P. Multilevel contextual 3-D CNNs for false positive reduction in pulmonary nodule detection. IEEE Trans. Biomed. Eng. 64, 1558–1567 (2017).
Lao, J. et al. A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme. Sci. Rep. 7, 10353 (2017).
Setio, A. A. A. et al. Validation, comparison, and combination of algorithms for automatic detection of pulmonary nodules in computed tomography images: the LUNA16 challenge. Med. Image Anal. 42, 1–13 (2017).
Ehteshami Bejnordi, B. et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA 318, 2199–2210 (2017).
Mohamed, A. A. et al. A deep learning method for classifying mammographic breast density categories. Med. Phys. 45, 314–321 (2018).
Khosravi, P., Kazemi, E., Imielinski, M., Elemento, O. & Hajirasouliha, I. Deep convolutional neural networks enable discrimination of heterogeneous digital pathology images. EBioMedicine 27, 317–328 (2018).
Xiao, Y., Wu, J., Lin, Z. & Zhao, X. A deep learning-based multi-model ensemble method for cancer prediction. Comput. Methods Prog. Biomed. 153, 1–9 (2018).
Marchetti, M. A. et al. Results of the 2016 International Skin Imaging Collaboration International Symposium on Biomedical Imaging challenge: comparison of the accuracy of computer algorithms to dermatologists for the diagnosis of melanoma from dermoscopic images. J. Am. Acad. Dermatol. 78, 270–277.e1 (2018).
Chen, P.-J. et al. Accurate classification of diminutive colorectal polyps using computer-aided analysis. Gastroenterology 154, 568–575 (2018).
Bychkov, D. et al. Deep learning based tissue analysis predicts outcome in colorectal cancer. Sci. Rep. 8, 3395 (2018).
Yasaka, K., Akai, H., Abe, O. & Kiryu, S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study. Radiology 286, 887–896 (2018).
Chang, K. et al. Residual convolutional neural network for the determination of IDH status in low- and high-grade gliomas from MR imaging. Clin. Cancer Res. 24, 1073–1081 (2018).
Ribli, D., Horváth, A., Unger, Z., Pollner, P. & Csabai, I. Detecting and classifying lesions in mammograms with deep learning. Sci. Rep. 8, 4165 (2018).
Chaudhary, K., Poirion, O. B., Lu, L. & Garmire, L. X. Deep learning-based multi-omics integration robustly predicts survival in liver cancer. Clin. Cancer Res. 24, 1248–1259 (2018).
Mobadersany, P. et al. Predicting cancer outcomes from histology and genomics using convolutional networks. Proc. Natl Acad. Sci. USA 115, E2970–E2979 (2018).
Saltz, J. et al. Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images. Cell Rep. 23, 181–193.e7 (2018).
van de Goor, R., van Hooren, M., Dingemans, A.-M., Kremer, B. & Kross, K. Training and validating a portable electronic nose for lung cancer screening. J. Thorac. Oncol. 13, 676–681 (2018).
Chang, H., Han, J., Zhong, C., Snijders, A. M. & Mao, J. Unsupervised transfer learning via multi-scale convolutional sparse coding for biomedical applications. IEEE Trans. Pattern Anal. Mach. Intell. 40, 1182–1194 (2018).
Han, S. S. et al. Classification of the clinical images for benign and malignant cutaneous tumors using a deep learning algorithm. J. Invest. Dermatol. 138, 1529–1538 (2018).
Hirasawa, T. et al. Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images. Gastric Cancer 21, 653–660 (2018).
Chang, P. et al. Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. Am. J. Neuroradiol. 39, 1201–1207 (2018).
Haenssle, H. A. et al. Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists. Ann. Oncol. 29, 1836–1842 (2018).
Coudray, N. et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat. Med. 24, 1559–1567 (2018).
Wang, P. et al. Development and validation of a deep-learning algorithm for the detection of polyps during colonoscopy. Nat. Biomed. Eng. 2, 741–748 (2018).
Urban, G. et al. Deep learning localizes and identifies polyps in real time with 96% accuracy in screening colonoscopy. Gastroenterology 155, 1069–1078.e8 (2018).
Rajpurkar, P. et al. Deep learning for chest radiograph diagnosis: a retrospective comparison of the CheXNeXt algorithm to practicing radiologists. PLoS Med. 15, e1002686 (2018).
Hosny, A. et al. Deep learning for lung cancer prognostication: a retrospective multi-cohort radiomics study. PLoS Med. 15, e1002711 (2018).
Nam, J. G. et al. Development and validation of deep learning-based automatic detection algorithm for malignant pulmonary nodules on chest radiographs. Radiology 290, 218–228 (2019).
Byrne, M. F. et al. Real-time differentiation of adenomatous and hyperplastic diminutive colorectal polyps during analysis of unaltered videos of standard colonoscopy using a deep learning model. Gut 68, 94–100 (2019).
Horie, Y. et al. Diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks. Gastrointest. Endosc. 89, 25–32 (2019).
Kather, J. N. et al. Predicting survival from colorectal cancer histology slides using deep learning: a retrospective multicenter study. PLoS Med. 16, e1002730 (2019).
Rodríguez-Ruiz, A. et al. Detection of breast cancer with mammography: effect of an artificial intelligence support system. Radiology 290, 305–314 (2019).
Li, X. et al. Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. Lancet Oncol. 20, 193–201 (2019).
Wang, S. et al. Predicting EGFR mutation status in lung adenocarcinoma on CT image using deep learning. Eur. Respir. J. 53, 1800986 (2019).
Brinker, T. J. et al. A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task. Eur. J. Cancer 111, 148–154 (2019).
Kickingereder, P. et al. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. Lancet Oncol. 20, 728–740 (2019).
Brinker, T. J. et al. Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task. Eur. J. Cancer 113, 47–54 (2019).
Choi, K. S., Choi, S. H. & Jeong, B. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network. Neuro Oncol. 21, 1197–1209 (2019).
Ardila, D. et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat. Med. 25, 954–961 (2019).
Yala, A., Lehman, C., Schuster, T., Portnoi, T. & Barzilay, R. A deep learning mammography-based model for improved breast cancer risk prediction. Radiology 292, 60–66 (2019).
Kather, J. N. et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat. Med. 25, 1054–1056 (2019).
Liu, Y. et al. Artificial intelligence-based breast cancer nodal metastasis detection: insights into the black box for pathologists. Arch. Pathol. Lab. Med. 143, 859–868 (2019).
Kehl, K. L. et al. Assessment of deep natural language processing in ascertaining oncologic outcomes from radiology reports. JAMA Oncol. 5, 1421–1429 (2019).
Campanella, G. et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat. Med. 25, 1301–1309 (2019).
Chen, P.-H. C. et al. An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis. Nat. Med. 25, 1453–1457 (2019).
Hu, L. et al. An observational study of deep learning and automated evaluation of cervical images for cancer screening. J. Natl Cancer Inst. 111, 923–932 (2019).
Rodriguez-Ruiz, A. et al. Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists. J. Natl Cancer Inst. 111, 916–922 (2019).
Wang, X. et al. Weakly supervised deep learning for whole slide lung cancer image analysis. IEEE Trans. Cybern. 50, 3950–3962 (2019).
Jurmeister, P. et al. Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases. Sci. Transl Med. 11, eaaw8513 (2019).
Courtiol, P. et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat. Med. 25, 1519–1525 (2019).
Wang, P. et al. Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study. Gut 68, 1813–1819 (2019).
Liao, F., Liang, M., Li, Z., Hu, X. & Song, S. Evaluate the malignancy of pulmonary nodules using the 3-D deep leaky noisy-OR network. IEEE Trans. Neural Netw. Learn. Syst. 30, 3484–3495 (2019).
Luo, H. et al. Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study. Lancet Oncol. 20, 1645–1654 (2019).
Wu, L. et al. Randomised controlled trial of WISENSE, a real-time quality improving system for monitoring blind spots during esophagogastroduodenoscopy. Gut 68, 2161–2169 (2019).
Shkolyar, E. et al. Augmented bladder tumor detection using deep learning. Eur. Urol. 76, 714–718 (2019).
Yamamoto, Y. et al. Automated acquisition of explainable knowledge from unannotated histopathology images. Nat. Commun. 10, 5642 (2019).
McKinney, S. M. et al. International evaluation of an AI system for breast cancer screening. Nature 577, 89–94 (2020).
Hollon, T. C. et al. Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks. Nat. Med. 26, 52–58 (2020).
Haenssle, H. A. et al. Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions. Ann. Oncol. 31, 137–143 (2020).
Ström, P. et al. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 21, 222–232 (2020).
Bulten, W. et al. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol. 21, 233–241 (2020).
Skrede, O.-J. et al. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Lancet 395, 350–360 (2020).
Saillard, C. et al. Predicting survival after hepatocellular carcinoma resection using deep-learning on histological slides. Hepatology 72, 2000–2013 (2020).
Jin, E. H. et al. Improved accuracy in optical diagnosis of colorectal polyps using convolutional neural networks with visual explanations. Gastroenterology 158, 2169–2179.e8 (2020).
de Groof, A. J. et al. Deep-learning system detects neoplasia in patients with Barrett’s esophagus with higher accuracy than endoscopists in a multistep training and validation study with benchmarking. Gastroenterology 158, 915–929.e4 (2020).
Bangalore Yogananda, C. G. et al. A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas. Neuro Oncol. 22, 402–411 (2020).
Zheng, X. et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat. Commun. 11, 1236 (2020).
Galateau Salle, F. et al. Comprehensive molecular and pathologic evaluation of transitional mesothelioma assisted by deep learning approach: a multi-institutional study of the International Mesothelioma Panel from the MESOPATH Reference Center. J. Thorac. Oncol. 15, 1037–1053 (2020).
Baldwin, D. R. et al. External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules. Thorax 75, 306–312 (2020).
Wang, P. et al. Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind randomised study. Lancet Gastroenterol. Hepatol. 5, 343–351 (2020).
Song, Q., Zheng, Y., Sheng, W. & Yang, J. Tridirectional transfer learning for predicting gastric cancer morbidity. IEEE Trans. Neural Netw. Learn. Syst. https://doi.org/10.1109/TNNLS.2020.2979486 (2020).
Dong, D. et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann. Oncol. 31, 912–920 (2020).
Shin, H. et al. Early-stage lung cancer diagnosis by deep learning-based spectroscopic analysis of circulating exosomes. ACS Nano 14, 5435–5444 (2020).
Kann, B. H. et al. Multi-institutional validation of deep learning for pretreatment identification of extranodal extension in head and neck squamous cell carcinoma. J. Clin. Oncol. 38, 1304–1311 (2020).
[No authors listed] AI diagnostics need attention. Nature 555, 285 (2018).
[No authors listed] Is digital medicine different? Lancet 392, 95 (2018).
Kawaguchi, K., Kaelbling, L. P. & Bengio, Y. Generalization in deep learning. arxiv https://arxiv.org/abs/1710.05468 (2017).
LeCun, Y. in Connectionism in Perspective (eds Pfeifer, R., Schreter, Z., Fogelman, F., & Steels, L.) 143–156 (Elsevier, 1989).
Neyshabur, B., Bhojanapalli, S., Mcallester, D. & Srebro, N. Exploring generalization in deep learning. Adv. Neural Inf. Process. Syst. 30, 5947–5956 (2017).
Pan, S. J. & Yang, Q. A survey on transfer learning. IEEE Trans. Knowl. Data Eng. 22, 1345–1359 (2010).
Weiss, K., Khoshgoftaar, T. M. & Wang, D. A survey of transfer learning. J. Big Data 3, 9 (2016).
Deng, J. et al. ImageNet: a large-scale hierarchical image database. Proc. IEEE Conf. Comput. Vis. Pattern Recognit. https://doi.org/10.1109/CVPR.2009.5206848 (2009).
Russakovsky, O. et al. ImageNet large scale visual recognition challenge. Int. J. Comput. Vis. 115, 211–252 (2015).
Shankar, S. et al. No classification without representation: assessing geodiversity issues in open data sets for the developing world. NIPS Workshop Mach. Learn. Dev. World https://arxiv.org/abs/1711.08536 (2017).
Geirhos, R. et al. ImageNet-trained CNNs are biased towards texture; increasing shape bias improves accuracy and robustness. Proc. Int. Conf. Learn. Represent. https://arxiv.org/abs/1811.12231 (2019).
Beyer, L., Hénaff, O. J., Kolesnikov, A., Zhai, X. & van den Oord, A. Are we done with ImageNet? arxiv https://arxiv.org/abs/2006.07159 (2020).
Sun, C., Shrivastava, A., Singh, S. & Gupta, A. Revisiting unreasonable effectiveness of data in deep learning era. Proc. IEEE Int. Conf. Comput. Vis. https://doi.org/10.1109/ICCV.2017.97 (2017).
Simard, P. Y., Steinkraus, D. & Platt, J. C. Best practices for convolutional neural networks applied to visual document analysis. Proc. 7th Int. Conf. Doc. Anal. Recognit. https://doi.org/10.1109/ICDAR.2003.1227801 (2003).
Baird, H. S. Document image defect models and their uses. Proc. 2nd Int. Conf. Doc. Anal. Recognit. https://doi.org/10.1109/ICDAR.1993.395781 (1993).
Stacke, K., Eilertsen, G., Unger, J. & Lundstrom, C. Measuring domain shift for deep learning in histopathology. IEEE J. Biomed. Health Inform. https://doi.org/10.1109/JBHI.2020.3032060 (2020).
Lakhani, P. & Sundaram, B. Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks. Radiology 284, 574–582 (2017).
Hussain, Z., Gimenez, F., Yi, D. & Rubin, D. Differential data augmentation techniques for medical imaging classification tasks. AMIA Annu. Symp. Proc. 2017, 979–984 (2018).
Sajjad, M. et al. Multi-grade brain tumor classification using deep CNN with extensive data augmentation. J. Comput. Sci. 30, 174–182 (2019).
Tellez, D. et al. Quantifying the effects of data augmentation and stain color normalization in convolutional neural networks for computational pathology. Med. Image Anal. 58, 101544 (2019).
Kerr, R. S. et al. Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. Lancet Oncol. 17, 1543–1557 (2016).
Szegedy, C., Vanhoucke, V., Ioffe, S., Shlens, J. & Wojna, Z. Rethinking the inception architecture for computer vision. Proc. IEEE Conf. Comput. Vis. Pattern Recognit. https://doi.org/10.1109/CVPR.2016.308 (2016).
Miller, R. G. J. Simultaneous Statistical Inference 2nd edn (Springer, 1981).
Hochberg, Y. & Tamhane, A. C. Multiple Comparison Procedures (Wiley, 2009).
Michiels, S., Koscielny, S. & Hill, C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365, 488–492 (2005).
Hastie, T., Tibshirani, R. & Friedman, J. The Elements of Statistical Learning 2nd edn (Springer-Verlag, 2009).
Russell, S. & Norvig, P. Artificial Intelligence: A Modern Approach 3rd edn (Prentice Hall, 2010).
Hemingway, H., Riley, R. D. & Altman, D. G. Ten steps towards improving prognosis research. BMJ 339, b4184 (2009).
Korevaar, D. A. et al. Facilitating prospective registration of diagnostic accuracy studies: a STARD initiative. Clin. Chem. 63, 1331–1341 (2017).
Ioannidis, J. P. A. The importance of predefined rules and prespecified statistical analyses: do not abandon significance. JAMA 321, 2067–2068 (2019).
Brodersen, K. H., Ong, C. S., Stephan, K. E. & Buhmann, J. M. The balanced accuracy and its posterior distribution. Proc. 20th Int. Conf. Pattern Recognit. https://doi.org/10.1109/ICPR.2010.764 (2010).
van den Hout, W. B. The area under an ROC curve with limited information. Med. Decis. Mak. 23, 160–166 (2003).
Fawcett, T. An introduction to ROC analysis. Pattern Recognit. Lett. 27, 861–874 (2006).
Harrell, F. E. Jr, Califf, R. M., Pryor, D. B., Lee, K. L. & Rosati, R. A. Evaluating the yield of medical tests. J. Am. Med. Assoc. 247, 2543–2546 (1982).
Lobo, J. M., Jiménez-Valverde, A. & Real, R. AUC: a misleading measure of the performance of predictive distribution models. Glob. Ecol. Biogeogr. 17, 145–151 (2008).
Voosen, P. How AI detectives are cracking open the black box of deep learning. Science https://www.sciencemag.org/news/2017/07/how-ai-detectives-are-cracking-open-black-box-deep-learning (2017).
Adadi, A. & Berrada, M. Peeking inside the black-box: a survey on explainable artificial intelligence (XAI). IEEE Access. 6, 52138–52160 (2018).
Barredo Arrieta, A. et al. Explainable artificial intelligence (XAI): concepts, taxonomies, opportunities and challenges toward responsible AI. Inf. Fusion. 58, 82–115 (2020).
Montavon, G., Samek, W. & Müller, K.-R. Methods for interpreting and understanding deep neural networks. Digit. Signal. Process. 73, 1–15 (2018).
Simonyan, K., Vedaldi, A. & Zisserman, A. Deep inside convolutional networks: visualising image classification models and saliency maps. Proc. Int. Conf. Learn. Represent. https://arxiv.org/abs/1312.6034 (2014).
Bach, S. et al. On pixel-wise explanations for non-linear classifier decisions by layer-wise relevance propagation. PLoS ONE 10, e0130140 (2015).
Sundararajan, M., Taly, A. & Yan, Q. Axiomatic attribution for deep networks. Proc. 34th Int. Conf. Mach. Learn. 70, 3319–3328 (2017).
Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M. & Granger, C. B. Fundamentals of Clinical Trials 5th edn (Springer, 2015).
van Luijn, H. E. M., Musschenga, A. W., Keus, R. B., Robinson, W. M. & Aaronson, N. K. Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members. Ann. Oncol. 13, 1307–1313 (2002).
Martin, L., Hutchens, M., Hawkins, C. & Radnov, A. How much do clinical trials cost? Nat. Rev. Drug Discov. 16, 381–382 (2017).
Teutsch, S. M. et al. The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP Working Group. Genet. Med. 11, 3–14 (2009).
Vollmer, S. et al. Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness. BMJ 368, l6927 (2020).
Chan, A.-W. et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 346, e7586 (2013).
Cruz Rivera, S. et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension. Nat. Med. 26, 1351–1363 (2020).
Moher, D. et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340, c869 (2010).
Collins, G. S. & Moons, K. G. M. Reporting of artificial intelligence prediction models. Lancet 393, 1577–1579 (2019).
Liu, X. et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat. Med. 26, 1364–1374 (2020).
[No authors listed] Should protocols for observational research be registered? Lancet 375, 348 (2010).
Loder, E., Groves, T. & MacAuley, D. Registration of observational studies. BMJ 340, c950 (2010).
Chambers, C. & Munafo, M. Trust in science would be improved by study pre-registration. The Guardian https://www.theguardian.com/science/blog/2013/jun/05/trust-in-science-study-pre-registration (2013).
Williams, R. J., Tse, T., Harlan, W. R. & Zarin, D. A. Registration of observational studies: is it time? Can. Med. Assoc. J. 182, 1638–1642 (2010).
Gill, J. & Prasad, V. Improving observational studies in the era of big data. Lancet 392, 716–717 (2018).
Sørensen, H. T. & Rothman, K. J. The prognosis for research. BMJ 340, c703 (2010).
Vandenbroucke, J. P. Registering observational research: second thoughts. Lancet 375, 982–983 (2010).
[No authors listed] The registration of observational studies — when metaphors go bad. Epidemiology 21, 607–609 (2010).
Andre, F. et al. Biomarker studies: a call for a comprehensive biomarker study registry. Nat. Rev. Clin. Oncol. 8, 171–176 (2011).
Hooft, L. & Bossuyt, P. M. Prospective registration of marker evaluation studies: time to act. Clin. Chem. 57, 1684–1686 (2011).
Altman, D. G. The time has come to register diagnostic and prognostic research. Clin. Chem. 60, 580–582 (2014).
Rifai, N. et al. Registering diagnostic and prognostic trials of tests: is it the right thing to do? Clin. Chem. 60, 1146–1152 (2014).
Rajkomar, A., Dean, J. & Kohane, I. Machine learning in medicine. N. Engl. J. Med. 380, 1347–1358 (2019).
Zou, J. & Schiebinger, L. AI can be sexist and racist — it’s time to make it fair. Nature 559, 324–326 (2018).
Adamson, A. S. & Smith, A. Machine learning and health care disparities in dermatology. JAMA Dermatol. 154, 1247–1248 (2018).
Vyas, D. A., Eisenstein, L. G. & Jones, D. S. Hidden in plain sight — reconsidering the use of race correction in clinical algorithms. N. Engl. J. Med. 383, 874–882 (2020).
Obermeyer, Z., Powers, B., Vogeli, C. & Mullainathan, S. Dissecting racial bias in an algorithm used to manage the health of populations. Science 366, 447–453 (2019).
Rajkomar, A., Hardt, M., Howell, M. D., Corrado, G. & Chin, M. H. Ensuring fairness in machine learning to advance health equity. Ann. Intern. Med. 169, 866–872 (2018).
Owens, K. & Walker, A. Those designing healthcare algorithms must become actively anti-racist. Nat. Med. 26, 1327–1328 (2020).
Moons, K. G. M. et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart 98, 691–698 (2012).
The authors thank M. Seiergren for assembling all figures, T. S. Hveem for discussions, T. Ystanes, H. A. Inderhaug and B. M. Sannes for setting up and maintaining our computer network and computational infrastructure, and the authors of Inception-v3 for making their code freely available under an open source licence (Apache License, version 2.0). The authors of this Perspective acknowledge funding from the Research Council of Norway through its IKTPLUSS Lighthouse programme (project number 259204).
The authors declare no competing interests.
Peer review information
Nature Reviews Cancer thanks J. Kather and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ClinicalTrials.gov registry: https://www.clinicaltrials.gov
International Standard Randomized Controlled Trial Number (ISRCTN) registry: https://www.isrctn.com
Journal Policies | Journal of Clinical Oncology : https://ascopubs.org/jco/authors/journal-policies
- Area under the receiver operating characteristic curve
(AUC). A performance metric measuring the concordance between a dichotomous outcome and the ranking of subjects provided by a continuous or categorical marker. An AUC of 50% indicates random guessing and 100% indicates perfect prediction. For dichotomous markers, the AUC and balanced accuracy are equivalent.
- Artificial neural networks
Mathematical functions mapping input data to output representations, structured as a directed graph of nodes and edges.
- Balanced accuracy
A classification performance metric calculated by averaging the proportion of true predicted outcomes across all possible outcomes. For dichotomous outcomes, this reduces to the average between the sensitivity and the specificity.
The ability of a model class, for example a particular network architecture, to express complicated correlations between input data and target output. Model classes with high capacity have the potential to produce models that are able to map training data to target outputs with a high degree of accuracy, but are also more prone to overfitting.
- Concordance index
(c-index). A performance metric measuring the concordance between a target outcome, usually defined by time to event data, and the ranking of subjects provided by a continuous or categorical marker. A c-index of 50% indicates random guessing and 100% indicates perfect prediction. For dichotomous outcomes, the c-index and the area under the receiver operating characteristic curve are equivalent.
- Deep learning
A class of machine learning methods that make use of successively more abstract representations of the input data to perform a specific task, typically implemented using artificial neural networks. They also consist of an objective function that compares the final output with a target output as well as an optimization method that is used to optimize the objective function.
- Deep learning models
Computational models obtained by training deep neural networks. Note that a single training of a neural network produces a sequence of models as each new optimization iteration produces a model slightly different from the previous one. A tuning data set may be used to select among these models.
- Deep learning systems
Systems utilizing one or more deep learning models to make predictions. A system’s output may be a function of the outputs of the models, for example by averaging and thresholding the model outputs.
- Development cohort
A cohort used for training and, sometimes, tuning and internal validation of a system.
- External cohorts
Also known as independent cohorts, these differ non-randomly from the development cohort. In cancer diagnostics, the external cohorts will often contain patients suspected of having the same disease or disease attribute, at risk of developing the same event or suspected to respond to the same treatment as patients in the development cohort. However, external cohorts may be intentionally more different from the development cohort.
- External validation
An evaluation of a system’s performance on an external cohort that did not influence the development of the system.
The ability of a system to perform similarly on subjects not included in training to on those included in the training. Poor generalizability can be caused by overfitting to the training data or by the lack of generally relevant features in the training data.
Utilizing noise or features in the training data that are not generally relevant for the prediction task but cause the system to perform better on the training sample.
- Supervised machine learning
A methodology in which learning occurs by mimicking the mapping of input data to target output labels. By contrast, the input data are not associated with any output labels in unsupervised learning.
Although frequently used by the machine learning community to refer to an evaluation of a system’s performance, we use ‘test’ to refer to evaluations other than external validations, for example internal validations.
Optimization of model parameters based on data.
Informed selection of hyperparameter values (parameters not optimized during training) based on data. Examples include the network architecture, optimization method and threshold for a model’s continuous output. The nomenclature in machine learning is to use ‘validation’ instead of ‘tuning’.
About this article
Cite this article
Kleppe, A., Skrede, OJ., De Raedt, S. et al. Designing deep learning studies in cancer diagnostics. Nat Rev Cancer 21, 199–211 (2021). https://doi.org/10.1038/s41568-020-00327-9
This article is cited by
Nature Medicine (2023)
Lightweight ResGRU: a deep learning-based prediction of SARS-CoV-2 (COVID-19) and its severity classification using multimodal chest radiography images
Neural Computing and Applications (2023)
Human-level COVID-19 diagnosis from low-dose CT scans using a two-stage time-distributed capsule network
Scientific Reports (2022)
npj Digital Medicine (2022)
Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis
npj Digital Medicine (2022)